CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxicity and cisplatin resistance

Publication | Closed Access

DOI

Citations

References

2019

Year

Vinay R. Sonawane, Mohd Usman Mohd Siddique, Linda Gatchie, Ibidapo S. Williams, Sandip B. Bharate, Venkatesan Jayaprakash, Barij Nayan Sinha, Bhabatosh Chaudhuri

European Journal of Pharmaceutical Sciences

Cisplatin ResistanceCyp1a1/cyp1b1 InhibitorsDrug TargetMedicineCyp EnzymesAnti-cancer AgentDrug DevelopmentPharmacologyCell BiologyDrug DiscoveryDrug Resistance